Uveal melanoma.
Kashyap S, Meel R, Singh L, Singh M.
Semin Diagn Pathol. 2016 May;33(3):141-7. doi: 10.1053/j.semdp.2015.10.005. Epub 2016 Mar 10.
Uveal melanoma: estimating prognosis.
Kaliki S, Shields CL, Shields JA.
Indian J Ophthalmol. 2015 Feb;63(2):93-102. doi: 10.4103/0301-4738.154367.
Iris melanocytoma.
Radovanović AB, Krnjaja BD, Jaksić V.
Srp Arh Celok Lek. 2016 Jan-Feb;144(1-2):74-6. doi: 10.2298/sarh1602074b.
Intraocular leiomyoma: Current concepts.
Tomar AS, Finger PT, Iacob CE.
Surv Ophthalmol. 2020 Jul-Aug;65(4):421-437. doi: 10.1016/j.survophthal.2019.12.008. Epub 2020 Jan 7.
Updates in imaging in ocular oncology.
Davila JR, Mruthyunjaya P.
F1000Res. 2019 Oct 1;8:F1000 Faculty Rev-1706. doi: 10.12688/f1000research.19979.1. eCollection 2019.
Obstacles to improving outcomes in the treatment of uveal melanoma.
Tsai KK, Bollin KB, Patel SP.
Cancer. 2018 Jul 1;124(13):2693-2703. doi: 10.1002/cncr.31284. Epub 2018 Mar 26.
Observations on intraocular leiomyomas.
Shields JA, Shields CL.
Trans Pa Acad Ophthalmol Otolaryngol. 1990;42:945-50.
Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
Bustamante P, Miyamoto D, Goyeneche A, de Alba Graue PG, Jin E, Tsering T, Dias AB, Burnier MN, Burnier JV.
Cancer Med. 2019 Dec;8(17):7265-7277. doi: 10.1002/cam4.2594. Epub 2019 Oct 7.
Ciliary body schwannoma.
Kim IT, Chang SD.
Acta Ophthalmol Scand. 1999 Aug;77(4):462-6. doi: 10.1034/j.1600-0420.1999.770423.x.
Quantitative assessment of the blood-aqueous barrier in human eyes with malignant or benign uveal tumors.
Küchle M, Nguyen NX, Naumann GO.
Am J Ophthalmol. 1994 Apr 15;117(4):521-8. doi: 10.1016/s0002-9394(14)70015-7.
